Stockreport

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals [Yahoo! Finance]

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)  (HLN) 
PDF Fabhalta for its third indication, C3 glomerulopathy (C3G). Pfizer PFE sold its remaining 7.3% stake in Haleon, thus fully exiting the consumer health company. Sanofi SN [Read more]